Content about Maryland

October 26, 2010

U.S. Marshals earlier this month seized articles of prescription and over-the-counter drug products from Tri-Med...

October 26, 2010

U.S. Marshals raided a warehouse in East Point, Ga., Wednesday, seizing an estimated $700,000 worth...

October 24, 2010

Retail pharmacies aren’t the only ones embracing technology like pharmacy automation. The government is doing...

MISSION, Kan. —Retail pharmacies aren’t the only ones embracing technology like pharmacy automation. The government is doing it, too.

October 20, 2010

Combining two antiviral drugs for HIV may raise the risks of life-threatening heart problems, the...

October 20, 2010

The Food and Drug Administration could decide that some generic drugs are not equivalent to...

BETHESDA, Md. The Food and Drug Administration could decide that some generic drugs are not equivalent to their branded counterparts, according to published reports.

 

October 19, 2010

Patients taking a certain class of drugs mostly used for prostate cancer may be at...

SILVER SPRING, Md. Patients taking a certain class of drugs mostly used for prostate cancer may be at higher risk of heart disease and diabetes, the Food and Drug Administration warned on Wednesday.

 

October 19, 2010

The Food and Drug Administration approved a drug for preventing strokes and blood clots in...

SILVER SPRING, Md. The Food and Drug Administration approved a drug for preventing strokes and blood clots in patients with abnormal heart rhythm, the agency said Tuesday.

 

The FDA announced the approval of Pradaxa (dabigatran etexilate) capsules, an anticlotting drug made by Boehringer Ingelheim for patients with atrial fibrillation, a type of abnormal heart rhythm that affects more than 2 million Americans.

 

 

October 19, 2010

CosaminASU was named a preferred joint health supplement in a new book, "FrameWork for the...

EDGEWOOD, Md. CosaminASU was named a preferred joint health supplement in a new book, "FrameWork for the Knee."

“In 'FrameWork for the Knee,' Dr. Nick DiNubile continues to stress the importance of exercise, nutrition and the mind in maintaining health,” said Troy Henderson, VP corporate operations and professional services at Nutramax Labs. “Physicians repeatedly recommended Cosamin products because of their high-quality ingredients and Nutramax Labs's strict adherence to [good manufacturing practices].”

 

October 17, 2010

A popular beauty treatment has won approval as a medical treatment as well....

SILVER SPRING, Md. A popular beauty treatment has won approval as a medical treatment as well.

 

The Food and Drug Administration announced Friday the approval of Allergan’s Botox (onabotulinumtoxinA) for preventing headaches in adult patients with chronic migraine.

 

 

October 14, 2010

The American Podiatric Medical Association recently issued a series of recommendations for runners, including the...

BETHESDA, Md. The American Podiatric Medical Association recently issued a series of recommendations for runners, including the use of a self-massager designed for post-athletic activities. Specifically, the association recommended Health Enterprises’ therapeutic hot-and-cold foot massager, a product that carries the APMA seal of approval.

 

October 13, 2010

The Food and Drug Administration on Thursday warned eight companies that their over-the-counter chelation products...

October 13, 2010

The Food and Drug Administration on Wednesday announced that Toby McAdam and Greta Armstrong, doing...

October 12, 2010

The Food and Drug Administration approved a drug to treat and prevent relapse after patients...

SILVER SPRING, Md. The Food and Drug Administration approved a drug to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment.

Vivitrol is an extended-release formulation of naltrexone -- which works to block opioid receptors in the brain -- administered by intramuscular injection once a month. It only is administered by a physician.

 

October 10, 2010

Humanity has come a long way since the days when people thought sickness came from...

October 10, 2010

While the fact that two Food and Drug Administration advisory committees collectively voted 15 opposed...

October 7, 2010

Clinical trial data indicating an increased risk of heart attack and stroke has led to...

SILVER SPRING, Md. Clinical trial data indicating an increased risk of heart attack and stroke has led to the removal from the market of an obesity drug made by Abbott, the Food and Drug Administration said Friday.

 

The FDA said the drug maker voluntarily withdrew the drug Meridia (sibutramine) following a required post-marketing trial showing that the drug increased by 16% the risk of nonfatal heart attacks and strokes, the need for resuscitation after the heart stopped and death.

 

 

October 6, 2010

The Food Marketing Institute recognized two companies for investing in the growth and development of...

October 6, 2010

Relatively healthy patients with Type 2 diabetes experienced a significant reduction in blood-sugar levels when...

BETHESDA, Md. Relatively healthy patients with Type 2 diabetes experienced a significant reduction in blood-sugar levels when taking an investigational treatment for Type 2 diabetes made by Spherix, the biotechnology company said Thursday.

 

Spherix announced results of a phase-3 trial of D-tagatose, which showed that the drug was more effective in American patients than in Indian patients.

 

 

October 4, 2010

Black & Decker announced the redesigned line of one of its most well-known products: the DustBuster....

TOWSON, Md. Black & Decker announced the redesigned line of one of its most well-known products: the DustBuster.

 

According to the company, the 14.4 V (CHV1410) and 15.6 V (CHV1510) models boast an innovative shape that allow users to operate the tool in ways that traditionally shaped hand vacs haven't performed.

 

 

October 4, 2010

Human Genome Sciences and Novartis have decided not to further develop an investigative biologic treatment...

ROCKVILLE, Md. Human Genome Sciences and Novartis have decided not to further develop an investigative biologic treatment for hepatitis C following the Food and Drug Administration’s decision to decline its approval, HGS said Tuesday.

 

HGS said it received a complete response letter from the FDA concerning the drug Zalbin (albinterferon alfa-2b). The FDA delivers a complete response letter to indicate that it has finished reviewing an application, but questions remain that preclude final approval.

 

 

October 3, 2010

The Food and Drug Administration has awarded almost $3 million for tuberculosis research, the agency...

September 30, 2010

The Food and Drug Administration is cracking down on companies that sell an unapproved treatment...

September 30, 2010

The University of Maryland School of Pharmacy's new pharmacy hall building officially will open Oct....

September 27, 2010

The Food and Drug Administration on Tuesday issued warning letters to three companies that manufacture...

SILVER SPRING, Md. The Food and Drug Administration on Tuesday issued warning letters to three companies that manufacture and market mouth rinse products with claims that they remove plaque above the gum line or promote healthy gums. According to the FDA, these claims suggested the products are effective in preventing gum disease when no such benefit has been demonstrated.

Warning letters were sent to: Johnson & Johnson (Listerine total care anti-cavity mouthwash), CVS (CVS complete care anti-cavity mouthwash), and Walgreens (Walgreen mouth rinse full action).

September 27, 2010

A regional supermarket owned by Supervalu said its president will retire Oct. 1....